Literature DB >> 18454174

Overexpression of mRNA-binding protein CRD-BP in malignant melanomas.

I Elcheva1, R S Tarapore, N Bhatia, V S Spiegelman.   

Abstract

Wnt/beta-catenin signaling pathway plays an important role in embryogenesis, stem cell maintenance, tumorigenesis and aging. Here, we show that RNA-binding protein, coding region determinant-binding protein (CRD-BP) (a transcriptional target of Wnt signaling pathway), is highly expressed in primary human malignant melanomas and melanoma cell lines with activated Wnt/beta-catenin signaling pathway. Upregulation of CRD-BP is associated with an elevated level of beta-TrCP1 ubiquitin ligase receptor and activation of nuclear transcriptional factors-kappa B (NF-kappaB) signaling. Knockdown of CRD-BP inhibits NF-kappaB activity, induces apoptosis, and suppresses proliferation and tumorigenic properties of melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454174     DOI: 10.1038/onc.2008.141

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein.

Authors:  Srikanta Goswami; Rohinton S Tarapore; Jessica J Teslaa; Yevgenya Grinblat; Vijayasaradhi Setaluri; Vladimir S Spiegelman
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

2.  Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.

Authors:  Evisabel A Craig; Vladimir S Spiegelman
Journal:  Pigment Cell Melanoma Res       Date:  2011-10-28       Impact factor: 4.693

3.  RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma.

Authors:  TaeWon Kim; Thomas Havighurst; KyungMann Kim; Scott J Hebbring; Zhan Ye; Juliet Aylward; Sunduz Keles; Yaohui G Xu; Vladimir S Spiegelman
Journal:  J Invest Dermatol       Date:  2016-11-14       Impact factor: 8.551

4.  Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Mohammad Saleem; Vaqar M Adhami; Vladimir S Spiegelman; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2010-08-23       Impact factor: 4.944

5.  The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Vaqar M Adhami; Vladimir S Spiegelman; Hasan Mukhtar
Journal:  Mol Nutr Food Res       Date:  2013-07-09       Impact factor: 5.914

6.  Cross-Regulation Between Wnt and NF-κB Signaling Pathways.

Authors:  Qiang Du; David A Geller
Journal:  For Immunopathol Dis Therap       Date:  2010

7.  MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.

Authors:  H Ohdaira; M Sekiguchi; K Miyata; K Yoshida
Journal:  Cell Prolif       Date:  2011-12-13       Impact factor: 6.831

8.  Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.

Authors:  Saja A Fakhraldeen; Rod J Clark; Avtar Roopra; Emily N Chin; Wei Huang; John Castorino; Kari B Wisinski; TaeWon Kim; Vladimir S Spiegelman; Caroline M Alexander
Journal:  J Biol Chem       Date:  2015-04-10       Impact factor: 5.157

9.  High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.

Authors:  Lily Mahapatra; Chengjian Mao; Neal Andruska; Chen Zhang; David J Shapiro
Journal:  J Biomol Screen       Date:  2013-10-09

10.  IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.

Authors:  Kathryn E Hamilton; Felicite K Noubissi; Prateek S Katti; Christopher M Hahn; Sonya R Davey; Emma T Lundsmith; Andres J Klein-Szanto; Andrew D Rhim; Vladimir S Spiegelman; Anil K Rustgi
Journal:  Carcinogenesis       Date:  2013-06-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.